Krause P, Brüggemann N, Völzmann S, Horn A, Kupsch A, Schneider G-H, Lohmann K, Kühn A
Department of Neurology, Charité, University Medicine Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany.
Institute of Neurogenetics and Department of Neurology, University of Lubeck, Lubeck, Germany.
J Neurol. 2015 Dec;262(12):2739-44. doi: 10.1007/s00415-015-7908-z. Epub 2015 Oct 20.
Deep brain stimulation (DBS) of the globus pallidus internus (GPi) is an established treatment in patients with severe dystonia. However, factors predicting outcome are largely unknown and motor improvement in DYT6 patients after DBS has been reported to be poorer as compared to, e.g., DYT1 patients. Here, we report the course of clinical improvement for up to 11 years of pallidal DBS in three male patients belonging to the same family with early-onset generalized or segmental dystonia due to a heterozygous THAP1 gene mutation (DYT6). All patients showed an initial effective response to pallidal DBS with a mean of 56.9 ± 11.7% improvement in the Burke-Fahn-Marsden Dystonia motor and 45.5 ± 22.4% in the disability score at 1-year follow-up. The long-term outcome of pallidal DBS was favorable in two patients (39, 67% motor improvement, respectively). Our findings demonstrate that motor improvement is variable and may depend on disease severity, disease duration, and clinical presentation. Overall, our observation supports pallidal DBS as an important treatment option in patients with DYT6 dystonia.
内侧苍白球(GPi)的深部脑刺激(DBS)是重度肌张力障碍患者的一种既定治疗方法。然而,预测疗效的因素在很大程度上尚不清楚,据报道,与DYT1患者相比,DYT6患者在DBS术后的运动改善较差。在此,我们报告了三名同一家族的男性患者接受苍白球DBS长达11年的临床改善过程,这些患者因杂合THAP1基因突变(DYT6)患有早发性全身性或节段性肌张力障碍。所有患者在苍白球DBS术后均出现初始有效反应,在1年随访时,伯克-法恩-马斯登肌张力障碍运动评分平均改善56.9±11.7%,残疾评分改善45.5±22.4%。两名患者(分别为39岁、67%)苍白球DBS的长期疗效良好。我们的研究结果表明,运动改善存在差异,可能取决于疾病严重程度、病程和临床表现。总体而言,我们的观察结果支持苍白球DBS作为DYT6肌张力障碍患者的一种重要治疗选择。